Pesquisas alternativas:
cross developed » across developed (Expandir a Pesquisa), process developed (Expandir a Pesquisa), crypts developed (Expandir a Pesquisa)
model develops » model developed (Expandir a Pesquisa), models developed (Expandir a Pesquisa), model developing (Expandir a Pesquisa)
developed type » developed ptypei (Expandir a Pesquisa), developed thyme (Expandir a Pesquisa), develop type (Expandir a Pesquisa)
develops type » develop type (Expandir a Pesquisa), developing type (Expandir a Pesquisa), develops age (Expandir a Pesquisa)
drugs model » drugs models (Expandir a Pesquisa), drugs mode (Expandir a Pesquisa), drug model (Expandir a Pesquisa)
drug cross » drugs cross (Expandir a Pesquisa), drugs across (Expandir a Pesquisa), drug class (Expandir a Pesquisa)
cross developed » across developed (Expandir a Pesquisa), process developed (Expandir a Pesquisa), crypts developed (Expandir a Pesquisa)
model develops » model developed (Expandir a Pesquisa), models developed (Expandir a Pesquisa), model developing (Expandir a Pesquisa)
developed type » developed ptypei (Expandir a Pesquisa), developed thyme (Expandir a Pesquisa), develop type (Expandir a Pesquisa)
develops type » develop type (Expandir a Pesquisa), developing type (Expandir a Pesquisa), develops age (Expandir a Pesquisa)
drugs model » drugs models (Expandir a Pesquisa), drugs mode (Expandir a Pesquisa), drug model (Expandir a Pesquisa)
drug cross » drugs cross (Expandir a Pesquisa), drugs across (Expandir a Pesquisa), drug class (Expandir a Pesquisa)
61
Por Ménez, Cécile, Alberich, Mélanie, Kansoh, Dalia, Blanchard, Alexandra, Lespine, Anne
Publicado no Antimicrob Agents Chemother (2016)
“... worms to MLs was determined in a larval development assay and compared with those of wild-type...”Publicado no Antimicrob Agents Chemother (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
62
Por Sinha, Siddharth, Goyal, Sukriti, Somvanshi, Pallavi, Grover, Abhinav
Publicado no Front Neurosci (2017)
“...-propanehydroxamic acid derivatives were used for developing three dimensional (3D) QSAR and pharmacophore models...”Publicado no Front Neurosci (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
63
Por Bean, Daniel M., Wu, Honghan, Iqbal, Ehtesham, Dzahini, Olubanke, Ibrahim, Zina M., Broadbent, Matthew, Stewart, Robert, Dobson, Richard J. B.
Publicado no Sci Rep (2017)
“... containing four types of node: drugs, protein targets, indications and adverse reactions. Using this graph...”Publicado no Sci Rep (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
64
Por Somarelli, Jason A., Rupprecht, Gabrielle, Altunel, Erdem, Flamant, Etienne M., Rao, Sneha, Sivaraj, Dharshan, Lazarides, Alexander L., Hoskinson, Sarah M., Sheth, Maya U., Cheng, Serene, Kim, So Young, Ware, Kathryn E., Agarwal, Anika, Cullen, Mark M., Selmic, Laura E., Everitt, Jeffrey I., McCall, Shannon J., Eward, Cindy, Eward, William C., Hsu, David S.
Publicado no Cancers (Basel) (2020)
“... of comparative oncology with patient-derived models of cancer and high-throughput chemical screens in a cross...”Publicado no Cancers (Basel) (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
65
“...PURPOSE: To develop an integrated mechanism-based modeling approach for the interspecies scaling...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
66
Por Zhu, Feng, Shi, Zhe, Qin, Chu, Tao, Lin, Liu, Xin, Xu, Feng, Zhang, Li, Song, Yang, Liu, Xianghui, Zhang, Jingxian, Han, Bucong, Zhang, Peng, Chen, Yuzong
Publicado em 2012
“... of 228 chemical types against 121 targets. Moreover, we added the data from our previous drug studies...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
67
Por Capone, Emily, Lamolinara, Alessia, Pastorino, Fabio, Gentile, Roberta, Ponziani, Sara, Di Vittorio, Giulia, D’Agostino, Daniela, Bibbò, Sandra, Rossi, Cosmo, Piccolo, Enza, Iacobelli, Valentina, Lattanzio, Rossano, Panella, Valeria, Sallese, Michele, De Laurenzi, Vincenzo, Giansanti, Francesco, Sala, Arturo, Iezzi, Manuela, Ponzoni, Mirco, Ippoliti, Rodolfo, Iacobelli, Stefano, Sala, Gianluca
Publicado no Cancers (Basel) (2020)
“...SIMPLE SUMMARY: Antibody Drug Conjugates are an emerging class of biopharmaceuticals that have seen...”Publicado no Cancers (Basel) (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
68
Por Heggannavar, Geetha B., Hiremath, Chinmay G., Achari, Divya D., Pangarkar, Vishwas G., Kariduraganavar, Mahadevappa Y.
Publicado no ACS Omega (2018)
“... (121.98 μg/mL). To understand the transport mechanism of drugs across the BBB, an in vitro BBB model using...”Publicado no ACS Omega (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
69
Por Zizioli, Daniela, Bernardi, Simona, Varinelli, Marco, Farina, Mirko, Mignani, Luca, Bosio, Katia, Finazzi, Dario, Monti, Eugenio, Polverelli, Nicola, Malagola, Michele, Borsani, Elisa, Borsani, Giuseppe, Russo, Domenico
Publicado no Cells (2021)
“... would be a robust CML model and a high-throughput drug screening tool....”Publicado no Cells (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
70
Por Ji, Bo-Ya, You, Zhu-Hong, Jiang, Han-Jing, Guo, Zhen-Hao, Zheng, Kai
Publicado no J Transl Med (2020)
“... existing computational methods only utilize the single type of interactions between drugs and proteins...”Publicado no J Transl Med (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
71
Por Barateau, Lucie, Jaussent, Isabelle, Lopez, Régis, Boutrel, Benjamin, Leu-Semenescu, Smaranda, Arnulf, Isabelle, Dauvilliers, Yves
Publicado no Sleep (2016)
“... and drug use, abuse and dependence in narcolepsy type 1 (NT1, hypocretin-deficient), narcolepsy type 2 (NT2...”Publicado no Sleep (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
72
Por De Pasquale, Daniele, Marino, Attilio, Tapeinos, Christos, Pucci, Carlotta, Rocchiccioli, Silvia, Michelucci, Elena, Finamore, Francesco, McDonnell, Liam, Scarpellini, Alice, Lauciello, Simone, Prato, Mirko, Larrañaga, Aitor, Drago, Filippo, Ciofani, Gianni
Publicado no Mater Des (2020)
“... crossing an in vitro blood-brain barrier model. The excellent targeting performances of the nanoplatform...”Publicado no Mater Des (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
73
Por Tanghe, Anouk, Celie, Bert, Shadid, Samyah, Rietzschel, Ernst, Op ‘t Roodt, Jos, Reesink, Koen D., Heyman, Elsa, Calders, Patrick
Publicado no Front Cardiovasc Med (2021)
“...Introduction: Patients with type 2 diabetes mellitus are at high risk to develop vascular...”Publicado no Front Cardiovasc Med (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
74
Por Lartey, Margaret, Asante-Quashie, Abena, Essel, Ama, Kenu, Ernest, Ganu, Vincent, Neequaye, Alfred
Publicado em 2014
“... but has many adverse effects. These adverse drug reactions (ADRs) lead to discontinuations, disease...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
75
Por L. V. Kondratyeva, T. V. Popkova, M. V. Cherkasova, A. M. Lila, E. L. Nasonov
Publicado em 2021-09-01
“.... Traditional risk factors for type 2 diabetes and the risk of its development in the next 10 years in patients...”Publicado em 2021-09-01
Obter o texto integral
Artigo
76
Por Tanaka, Mamoru, Kataoka, Hiromi, Yano, Shigenobu, Ohi, Hiromi, Kawamoto, Keisuke, Shibahara, Takashi, Mizoshita, Tsutomu, Mori, Yoshinori, Tanida, Satoshi, Kamiya, Takeshi, Joh, Takashi
Publicado em 2013
“...BACKGROUND: Cisplatin (CDDP) is the most frequently used chemotherapeutic agent for various types...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
77
Por Quach, Lien A., Wanke, Christine A, Schmid, Christopher H., Gorbach, Sherwood L., Mwamburi, D. Mkaya, Mayer, Kenneth H., Spiegelman, Donna, Tang, Alice M.
Publicado em 2008
“... and depression were not associated with BMI in the final model. In conclusion, BMI was lower in drug users than...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
78
Por Boichuk, Sergei, Galembikova, Aigul, Sitenkov, Alexandr, Khusnutdinov, Ramil, Dunaev, Pavel, Valeeva, Elena, Usolova, Natalia
Publicado no Oncol Lett (2017)
“... to the development of multi-drug resistance (MDR). Therefore, an improved understanding of MDR mechanisms may improve...”Publicado no Oncol Lett (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
79
Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Diabetes...
“... (3D QSAR) pharmacophore models, virtual screening, molecular docking, and de novo Evolution...”Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
80
Por Yang, Xilin, Zhao, Hailu, Sui, Yi, Ma, Ronald C.W., So, Wing Yee, Ko, Gary T.C., Kong, Alice P.S., Ozaki, Risa, Yeung, Chun Yip, Xu, Gang, Tong, Peter C.Y., Chan, Juliana C.N.
Publicado em 2009
“...OBJECTIVE: Clinical and experimental studies suggest cross-talk between lipid metabolism...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo